KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Shares Issued (2016 - 2025)

Quest Diagnostics' Shares Issued history spans 17 years, with the latest figure at $18.0 million for Q4 2025.

  • For Q4 2025, Shares Issued fell 14.29% year-over-year to $18.0 million; the TTM value through Dec 2025 reached $79.0 million, up 8.22%, while the annual FY2025 figure was $79.0 million, 8.22% up from the prior year.
  • Shares Issued for Q4 2025 was $18.0 million at Quest Diagnostics, down from $19.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $58.0 million in Q2 2022 and bottomed at $10.0 million in Q1 2022.
  • The 5-year median for Shares Issued is $21.0 million (2021), against an average of $23.8 million.
  • The largest annual shift saw Shares Issued plummeted 78.75% in 2021 before it skyrocketed 150.0% in 2023.
  • A 5-year view of Shares Issued shows it stood at $21.0 million in 2021, then rose by 28.57% to $27.0 million in 2022, then plummeted by 55.56% to $12.0 million in 2023, then soared by 75.0% to $21.0 million in 2024, then dropped by 14.29% to $18.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Shares Issued are $18.0 million (Q4 2025), $19.0 million (Q3 2025), and $13.0 million (Q2 2025).